What is the effect of Lithium orotate for APOE4 carriers?
Lithium orotate is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Browse by intervention
One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.
How to read this
Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.
Read the full methods and limitsLithium orotate is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Collecting evidence
Lithium orotate is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
Too early to say. Prescription lithium may slow decline in small trials of people with mild memory problems, in Denmark dementia was less common where drinking water had the most lithium, and a 2025 Nature study found low brain lithium early in Alzheimer's, but lithium orotate itself has never been tested in a human trial. Some people report side effects such as poor sleep, so talk to your doctor before trying it.
APOE4-specific evidence: none
No human trial has tested lithium orotate; the hopeful signals come from prescription lithium in small trials, drinking-water studies and a mouse study, so the supplement's benefit and safety are unproven.
Aron 2025, Nature
Animal or lab study
Brain lithium was low in people with MCI; in mice, lithium depletion sped Alzheimer's changes and lithium orotate reversed them (animal data).
Read on PubMed (opens in a new tab)Matsunaga 2015, Journal of Alzheimer's DiseaseGrade B
3 trials, 232 people with MCI or Alzheimer's: prescription lithium slowed cognitive decline versus placebo.
Read on PubMed (opens in a new tab)Kessing 2017, JAMA PsychiatryGrade C
Denmark, 73,731 people with dementia and 733,653 controls: dementia was less common above 15 micrograms per litre of lithium in drinking water, about level at 10-15 and more common at 5-10; confounding by area was not excluded.
Read on PubMed (opens in a new tab)Hajek 2026, British Journal of Psychiatry
Animal or lab study
Commentary: no study shows lithium orotate acts differently from other lithium salts once in the body.
Read on PubMed (opens in a new tab)Strawbridge 2025, Canadian Journal of Psychiatry
Survey of supplement users: side effects and withdrawal effects were more common than expected.
Read on PubMed (opens in a new tab)McKnight 2012, LancetGrade A
At prescription doses, lithium raises TSH and affects kidney function.
Read on PubMed (opens in a new tab)1 passage against
Now showing: Donna Dorrance · 21:32
Open on YouTube (opens in a new tab)
One carrier stopped lithium orotate because it caused insomnia.
“lithium orotate that's supposed to be good for you. And for me, it caused insomnia.”
Donna Dorrance, Phoenix member and APOE4/4 carrier, aged 72
Last reviewed
Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.
Want to see how this affects you? Phoenix tracks it beside your labs and how you feel.
Apply to join PhoenixLithium orotate · 2 outcomes shown.
HDL cholesterol: Increase 24 %
Cases: 1
Context affected
Lithium orotate
?Collecting evidenceOne curated lithium-orotate case raised HDL cholesterol 24%; the report prints no paired values or elapsed days.
Not explained by the science yetLow-dose lithium orotate is a nutritional supplement with no established lipid mechanism; the psychiatric-dose lithium carbonate literature is a different drug and dose entirely.
Collecting evidence
Lithium orotate is being tracked against HDL cholesterol, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
Context affected this result: Not printed as of Release 001: low-dose lithium orotate has no established lipid mechanism in humans, and it never leads a printed combination. It is not published as a driver.
LDL cholesterol: Decrease 15 %
Cases: 1
Context affected
Lithium orotate
?Collecting evidenceOne curated lithium-orotate case lowered LDL cholesterol 15%; the report prints no paired values or elapsed days.
Not explained by the science yetSame absence of a lithium-orotate lipid mechanism or human data applies to LDL.
Collecting evidence
Lithium orotate is being tracked against LDL cholesterol, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
Context affected this result: Not printed as of Release 001: low-dose lithium orotate has no established lipid mechanism in humans, and it never leads a printed combination. It is not published as a driver.
The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.
Turn evidence into your next test
476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.
Full research index
Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.